Company: HCTI
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-045994
Chunk: 4

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
 in cash and cash equivalents 
     6,806  
     (933)
  
    Cash and cash equivalents 

    Cash and cash equivalents at the beginning of the period 
    $20  
    $1,234 
  
    Cash and cash equivalents at the end of the period 
    $6,826  
    $301 

    Non-cash investing and financing activities 

    Supplementary disclosure of cash flows information 

    Interest 
     413  
     149 
  
    Conversion of debt to equity 
     1,191  
     - 

The accompanying notes are an integral part of
these condensed consolidated financial statements.

4

HEALTHCARE TRIANGLE, INC.

 Notes To Condensed Consolidated Financial
Statements

(Unaudited)

(In thousands except share and per share data)

1) Organization and Description of Business

Healthcare Triangle Inc. (“the Company”)
was incorporated under the laws of the State of Nevada on October 29, 2019, and then converted into a Delaware corporation on April 24,
2020, to provide IT and data services to the Healthcare and Life Sciences (‘HCLS”) industry. On January 1, 2020, the Company
acquired the Life Sciences Business of SecureKloud Technologies Inc. (“Parent”) and on May 8, 2020, the Company acquired Cornerstone
Advisors Group LLC (Healthcare Business) from its Parent.

Company reinforces healthcare progress through
breakthrough technology and extensive industry know-how. Company support healthcare providers and payors, hospitals and pharma/life sciences
organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business
agility and accelerate responding to immediate business needs and competitive threats. The highly regulated HCLS industry
turn to Company for expertise in digital transformation on the cloud, security and compliance, develops, data lifecycle management, healthcare
interoperability, clinical and business performance optimization. 

Company concentrates on accelerating value to
the three healthcare sectors:

    1.
    Pharmaceutical companies, which require improved efficiencies in the clinical trial process. Company modernizes their IT infrastructure to advance the clinical trial process to drug discovery and delivery.

    2.
    Hospitals and health systems, which face interoperability challenges as mergers, acquisitions and partnerships drive increasing need for integrated healthcare infrastructures. Company’s health IT expertise optimizes providers’ enterprise digital structure needs connecting